Statistical controversies in cancer research: Using standardized effect size graphs to enhance interpretability of cancer-related clinical trials with patient-reported outcomes

Melanie L. Bell, M. H. Fiero, H. M. Dhillon, V. J. Bray, J. L. Vardy

Research output: Contribution to journalArticle

6 Scopus citations

Abstract

Patient reported outcomes (PROs) are becoming increasingly important in cancer studies, particularly with the emphasis on patient centered outcome research. However, multiple PROs, using different scales, with different directions of favorability are often used within a trial, making interpretation difficult. To enhance interpretability, we propose the use of a standardized effect size graph, which shows all PROs from a study on the same figure, on the same scale. Plotting standardized effects with their 95% confidence intervals (CIs) on a single graph clearly showing the null value conveys a comprehensive picture of trial results. We demonstrate how to create such a graph using data from a randomized controlled trial that measured 12 PROs at two time points. The 24 effect sizes and CIs are shown on one graph and clearly indicate that the intervention is effective and sustained.

Original languageEnglish (US)
Pages (from-to)1730-1733
Number of pages4
JournalAnnals of Oncology
Volume28
Issue number8
DOIs
StatePublished - Aug 1 2017

Keywords

  • Cancer
  • Effect size
  • Graphs
  • Patient-reported outcomes
  • Quality of life

ASJC Scopus subject areas

  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'Statistical controversies in cancer research: Using standardized effect size graphs to enhance interpretability of cancer-related clinical trials with patient-reported outcomes'. Together they form a unique fingerprint.

  • Cite this